Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm
- 30 September 2005
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 147 (3), S78-S82
- https://doi.org/10.1016/j.jpeds.2005.08.017
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Population-Based Newborn Screening for Genetic Disorders When Multiple Mutation DNA Testing Is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier DetectionsPEDIATRICS, 2004
- Newborn Screening for Cystic FibrosisPediatric Annals, 2003
- Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.European Journal of Pediatrics, 2002
- A Missense Cystic Fibrosis Transmembrane Conductance Regulator Mutation With Variable PhenotypePEDIATRICS, 1997
- Newborn Screening for Cystic Fibrosis in Wisconsin: Comparison of Biochemical and Molecular MethodsPEDIATRICS, 1997
- A Cystic Fibrosis Mutation Associated with Mild Lung DiseaseThe New England Journal of Medicine, 1995
- Mutations in CFTR associated with mild-disease-form CI- channels with altered pore propertiesNature, 1993
- Efficacy of Statewide Neonatal Screening for Cystic Fibrosis by Assay of Trypsinogen ConcentrationsThe New England Journal of Medicine, 1991
- DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORNThe Lancet, 1979
- Intestinal Obstruction of the Newborn InfantThe New England Journal of Medicine, 1961